Systemic inflammation factors as survival prognosis markers in ovarian neoplasm and the relationship with cancer-associated inflammatory mediators-a review

At the level of the genital system, ovarian neoplasm is the most frequent cause of morbidity and mortality. In the specialized literature, the coexistence of an inflammatory process is admitted from the early stages of the evolution of this pathology. Starting from the importance of this process, both in determinism and in the evolution of carcinogenesis and summarizing the field of knowledge, for this study we considered two objectives: the first was the presentation of the pathogenic mechanism, through which chronic +ovarian inflammation is involved in the process of carcinogenesis, and the second is the justification of the clinical utility of the three parameters, accepted as biomarkers of systemic inflammation: neutrophil-lymphocyte ratio, platelet lymphocyte ratio, and lymphocyte-monocyte ratio in the assessment of prognosis. The study highlights the acceptance of these hematological parameters, with practical utility, as prognostic biomarkers in ovarian cancer, based on the intrinsic link with cancer-associated inflammatory mediators. Based on the data from the specialized literature, the conclusion is that in ovarian cancer, the inflammatory process induced by the presence of the tumor, induces changes in the types of circulating leukocytes, with immediate effects on the markers of systemic inflammation.

The Concept of Debulking in Ovarian Cancer

Ovarian cancer is the most lethal gynecological oncological condition. He responds to primary surgical treatment, although the vast majority of patients are diagnosed in advanced stages of the disease, in which the rate of recurrences is increased and the chance of survival at 5 years is below 45%.

Importance of Surgical Treatment in Ovarian Neoplasm

Ovarian neoplasm responds to primary surgical treatment, although the vast majority of patients are diagnosed in advanced stages of the disease, in which the rate of relapses is increased and the chance of survival at 5 years is below 45%. It represents the most lethal gynecological oncological conditio

Screening in Ovarian Neoplasm

Ovarian neoplasm is extremely aggressive and has a high mortality rate among affected women; therefore, the crucial role of screening tests is easy to understand. Prevention and early diagnosis should be essential priorities in the management of this malignancy. Since a complete and correct clinical examination can select the cases that require specialized investigations, we can consider it a first screening test.

Screening in Ovarian Neoplasm

Ovarian neoplasm is extremely aggressive and has a high mortality rate among affected women; therefore, the crucial role of screening tests is easy to understand. Prevention and early diagnosis should be essential priorities in the management of this malignancy. Since a complete and correct clinical examination can select the cases that require specialized investigations, we can consider it a first screening test.

Preserving Fertility in Ovarian Cancer

In the last decades, by improving the oncological treatment, the life expectancy of the adolescent patients with ovarian cancer has been increased and more than that they have succeeded by a real chance of obtaining a future pregnancy. Thus, the problem of preserving fertility becomes paramount both for patients who have suffered from an oncological disease and for those up to the age of 40 who have fertility problems.

Preserving Fertility in Ovarian Cancer

In the last decades, by improving the oncological treatment, the life expectancy of the adolescent patients with ovarian cancer has been increased and more than that they have succeeded by a real chance of obtaining a future pregnancy. Thus, the problem of preserving fertility becomes paramount both for patients who have suffered from an oncological disease and for those up to the age of 40 who have fertility problems.

[The etiopathogenetic and therapeutic correlations in chronic gastritis]

Haot et al. described in 1985 a new histopathologic entity, the lymphocytic gastritis, characterised by large number of intraepithelial T cells. The condition is usually symptomatic and related to an endoscopic form of gastropathy; it has an easily recognizable histology. According to The Sydney System it is classified as a special form; no etiopathogenic relation is established. The clinical significance and treatment are currently unclear. In one case, affected by peripheric T cell disfunction, there was significant clinical, endoscopic and histologic improvement after vagotomy, hemigastrectomy and total duodenal diversion. The possible favorable effect of surgery on lymphocytic gastritis, a diffuse gastric pathology, is discussed. To our knowledge this has not been reported before.

[The etiopathogenetic and therapeutic correlations in chronic lymphocytic gastritis]

Haot et. al. (1,2) described in 1985 a new histopathologic entity, the lymphocytic gastritis, characterised by large number of intraepithelial T cells. The condition is usually symptomatic and related to an endoscopic form of gastropathy; it has an easily recognizable histology. According to The Sydney System it is classified as a special form (3); no etiopathogenic relation is established. The clinical significance and treatment are currently unclear (4). In one case, affected by peripheric T cell disfunction, there was significant clinical, endoscopic and histologic improvement after vagotomy, hemigastrectomy and total duodenal diversion. The possible favorable effect of surgery on lymphocytic gastritis, a diffuse gastric pathology, is discussed. To our knowledge this has not been reported before.